1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [f4db12cb-d4cd-4a9e-8ba8-b96f51f8d603] => Array ( [runtime-id] => f4db12cb-d4cd-4a9e-8ba8-b96f51f8d603 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [36c0c366-bc40-46f9-99ba-a03d2bd40373] => Array ( [runtime-id] => 36c0c366-bc40-46f9-99ba-a03d2bd40373 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;a820ebda540f0637f5a56d0cb4298771799da777 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [f4db12cb-d4cd-4a9e-8ba8-b96f51f8d603] => Array ( [runtime-id] => f4db12cb-d4cd-4a9e-8ba8-b96f51f8d603 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [36c0c366-bc40-46f9-99ba-a03d2bd40373] => Array ( [runtime-id] => 36c0c366-bc40-46f9-99ba-a03d2bd40373 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;a820ebda540f0637f5a56d0cb4298771799da777 ) ) )Table 1:Vascular ICH etiologies identified by MDCTA
Etiology Retrospective Cohort (n = 91) Prospective Cohort (n = 29) All Patients (n = 120) No. % No. % No. % AVM 40 44 15 51.7 55 45.8 Aneurysm 21a 23 5 17.2 26a 21.7 DVST 17 18.7 3 10.3 20 16.7 AVF 8 8.8 3 10.3 11 9.2 Vasculopathy 3 3.3 1b 3.5 4b 3.3 Moyamoya 2 2.2 2 7 4 3.3
a Includes 3 pseudoaneurysms.
b Includes a patient in whom vasculitis led to pseudoaneurysm formation and rupture.